Vascular function in preeclampsia

Cardiovascular Research

Volumn 47, Issue 1, 2000, Pages 38-48

  Vanwijk, Marja J ^a   Kublickiene, Karolina ^b   Boer, Kees ^a   VanBavel, Ed ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arteries; Endothelial function; Hemodynamics; Hypertension; Vasoconstriction dilation

Indexed keywords

HEMODYNAMICS; HUMAN; MATERNAL MORBIDITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

ADULT; ARTERIES; ATRIAL NATRIURETIC FACTOR; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; GENOTYPE; HUMANS; LYMPHOKINES; MUSCLE, SMOOTH, VASCULAR; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; THROMBOXANE A2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASOCONSTRICTION;

EID: 0034125884     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00087-0     Document Type: Review

References (145)

1. Jonsdottir L.S., Arngrimsson R., Geirsson R.T., Sigvaldason H., Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 74:1995;772-776.
2. Johnson A., Townshend P., Yudkin P., Bull D., Lkinson A.R. Functional abilities at age 4 years of children born before 29 weeks of gestation. BMJ. 306:1993;1715-1718.
3. MacGillivray I., Rose G.A., Rowe B. Blood pressure survey in pregnancy. Clin Sci. 37:1969;395-407.
4. Duvekot J.J., Peeters L.L.H. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv. 49:1994;S1-S14.
5. Robson S.C., Hunter S., Boys R.J., Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 256:1989;H1060-H1065.
6. Ginsburg J., Duncan S.L. Peripheral circulation in hypertensive pregnancy. Cardiovasc Res. 1:1967;356-361.
7. Dunlop W. Investigations into the influence of posture on renal plasma flow and glomerular filtration rate during late pregnancy. Br J Obstet Gynaecol. 83:1976;17-23.
8. Assali N.S., Raumano L., Peltonen T. Uterine and fetal bloodflow and oxygen consumption in early human pregnancy. Am J Obstet Gynecol. 79:1960;1307-1312.
9. Poston L., McCarthy A.L., Ritter J.M. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther. 65:1995;215-239.
10. Easterling T.R., Benedetti T.J., Schmucker B.C., Millard S.P. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol. 76:1990;1061-1069.
11. Kuzniar J., Piela A., Skret A., Szmigiel Z., Zaczek T. Echocardiographic estimation of hemodynamics in hypertensive pregnancy. Am J Obstet Gynecol. 144:1982;430-437.
12. Assali N.S., Holm L.W., Parker H.M. Systemic and regional hemodynamic alterations in toxemia. Circulation. 30:1964;53-57.
13. Lees M.M. Central circulatory responses in normotensive and hypertensive pregnancy. Postgrad Med J. 55:1979;311-314.
14. Benedetti T.J., Cotton D.T., Read J.C., Miller F.C. Hemodynamic observations in severe pre-eclampsia with a flow-directed pulmonary artery catheter. Am J Obstet Gynecol. 136:1980;465-470.
15. Yang J.M., Yang Y.C., Wang K.G. Central and peripheral hemodynamics in severe preeclampsia. Acta Obstet Gynecol Scand. 75:1996;120-126.
16. Visser W., Wallenburg H.C. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 17:1991;1072-1077.
17. Rankin J.H.G. Interactions between the maternal and fetal placental bloodflows. Rosenfeld C.R. The uterine circulation. 1989;175-190 Perinatology Press, Ithaca, New York.
18. Meekins J.W., Pijnenborg R., Anssens M., McFadyen I.R., VanAsshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 101:1994;669-674.
19. Pijnenborg R., Anthony J., Davey D.A., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 98:1991;648-655.
20. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 99:1997;2152-2164.
21. Hunt J.S., Chen H.L., Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod. 54:1996;4554-4562.
22. Wheeler T., Evans P.W., Anthony F.W., Godfrey K.M., Osmond C. Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth. Hum Reprod. 14:1999;1619-1623.
23. Genbacev O., Zhou Y., Ludlow J.W., Fisher S.J. Regulation of human placental development by oxygen tension. Science. 277:1997;1669-1672.
24. Genbacev O., Joslin R., Damsky C.H., Polliotti B.M., Fisher S.J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 97:1996;540-550.
25. Walsh S.W., Parisi V.M. The role of arachidonic acid metabolites in preeclampsia. Semin Perinatol. 10:1986;334-355.
26. Chesley L.C., Annitto J.E., Cosgrove R.A. The familial factor in toxemia of pregnancy. Obstet Gynecol. 32:1968;303-311.
27. Thornton J.G., Onwude J.L. Pre-eclampsia: discordance among identical twins. BMJ. 303:1991;1241-1242.
28. Cooper D.W., Hill J.A., Chesley L.C., Bryans C.I. Genetic control of susceptibility to eclampsia and miscarriage. Br J Obstet Gynaecol. 95:1988;644-653.
29. Cooper D.W., Brennecke S.P., Wilton A.N. Genetics of preeclampsia. Hypert Pregn. 12:1999;1-23.
30. Arngrimsson R., Bjornsson H., Geirsson R. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypert Pregn. 14:1995;27-38.
31. Morgan T., Ward K. New insights into the genetics of preeclampsia. Semin Perinatol. 23:1999;14-23.
32. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
33. Ward K., Hata A., Jeunemaitre X., et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 4:1993;59-61.
34. Wilton A.N., Kaye J.A., Guo G., et al. Is angiotensin a good candidate gene for preeclampsia. Hypert Pregn. 14:1995;251-260.
35. Arngrimsson R., Hayward C., Nadaud S., et al. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet. 61:1997;354-362.
36. Kilpatrick D.C. Influence of human leukocyte antigen and tumour necrosis factor genes on the development of pre-eclampsia. Hum Reprod Update. 5:1999;94-102.
37. Dekker G.A., de Vries J.I., Doelitzsch P.M., et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 173:1995;1042-1048.
38. Taylor R.N. Review: immunobiology of preeclampsia. Am J Reprod Immunol. 37:1997;79-86.
39. Dekker G.A., Sibai B.M. The immunology of preeclampsia. Semin Perinatol. 23:1999;24-33.
40. Taufield P.A., Suthanthiran M., Ales K., et al. Maternal-fetal immunity: presence of specific cellular hyporesponsiveness and humoral suppressor activity in normal pregnancy and their absence in preeclampsia. Clin Exp Hypertens. 2:1983;123-131.
41. Loke Y.W.K., King A. Immunology of human placental implantation: clinical implications of our current understanding. Mol Med Today. 3:1997;153-159.
42. Hara N., Fujii T., Yamashita T., et al. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody '87G' and anti-cytokeratin antibody 'CAM5.2'. Am J Reprod Immunol. 36:1996;349-358.
43. Lim K.H., Zhou Y., Janatpour M., et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol. 151:1997;1809-1818.
44. Anonymous, ACOG technical bulletin. Hypertension in pregnancy. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996;53:175-183.
45. van Pampus M.G., Dekker G.A., Wolf H., et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol. 180:1999;1146-1150.
46. Rodgers G.M., Taylor R.N., Roberts J.M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol. 159:1988;908-914.
47. Tsukimori K., Maeda H., Shingu M., et al. The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet Gynecol. 80:1992;229-233.
48. de Groot C.J., Davidge S.T., Friedman S.A., et al. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass. Am J Obstet Gynecol. 172:1995;976-985.
49. Baker P.N., Davidge S.T., Roberts J.M. Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension. 26:1995;244-248.
50. Lorentzen B., Endresen M.J., Hovig T., Haug E., Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res. 63:1991;363-372.
51. Haller H., Hempel A., Homuth V., et al. Endothelial-cell permeability and protein kinase C in pre-eclampsia. Lancet. 351:1998;945-949.
52. Ashworth J.R., Warren A.Y., Johnson I.R., Baker P.N. Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol. 105:1998;459-461.
53. Jones C.J., Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta. 1:1980;61-76.
54. MacLennan A.H., Sharp F., Shaw-Dunn J. The ultrastructure of human trophoblast in spontaneous and induced hypoxia using a system of organ culture. A comparison with uultrastructural changes in pre-eclampsia and placental insufficiency. J Obstet Gynaecol Br Commonw. 79:1972;113-121.
55. Attwood H.D., Park W.W. Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw. 64:1961;611-617.
56. Chua S., Wilkins T., Sargent I.L., Redman C.W. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol. 98:1991;973-979.
57. Knight M., Redman C.W., Linton E.A., Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 105:1998;632-640.
58. Smarason A.K., Sargent I.L., Starkey P.M., Redman C.W. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol. 100:1993;943-949.
59. Cockell A.P., Learmont J.G., Smarason A.K., et al. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol. 104:1997;235-240.
60. Walsh S.W. The role of fatty acid peroxidation and antioxidant status in normal pregnancy and in pregnancy complicated by preeclampsia. World Rev Nutr Diet. 76:1994;114-118.
61. Dekker G.A., VanGeyn H.P. Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives. J Perinat Med. 24:1996;99-117.
62. Wang Y.P., Walsh S.W., Kuo J.D., Zhang J.Y. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol. 165:1991;1690-1694.
63. Barden A., Beilin L.J., Ritchie J., et al. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci. 91:1996;711-718.
64. Staff A.C., Ranheim T., Khoury J., Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol. 180:1999;587-592.
65. Wisdom S.J., Wilson R., McKillopp J.H., Walker J.J. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol. 165:1991;1701-1704.
66. Mikhail M.S., Anyaegbunam A., Garfinkel D., et al. Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol. 171:1994;150-157.
67. Tsukimori K., Maeda H., Ishida K., et al. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol. 81:1993;536-540.
68. Wang Y., Walsh S.W. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig. 3:1996;179-184.
69. von Dadelszen P., Hurst G., Redman C.W. Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum Reprod. 14:1999;919-924.
70. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 354:1999;810-816.
71. Hubel C.A., Roberts J.M., Taylor R.N., et al. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol. 161:1989;1025-1034.
72. Zammit V.C., Whitworth J.A., Brown M.A. Endothelium-derived prostacyclin: effect of serum from women with normal and hypertensive pregnancy. Clin Sci. 82:1992;383-388.
73. Endresen M.J., Tosti E., Heimli H., Lorentzen B., Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest. 54:1994;549-557.
74. Ibdah J.A., Bennett M.J., Rinaldo P., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 340:1999;1723-1731.
75. Strauss A.W., Bennett M.J., Rinaldo P., et al. Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin Perinatol. 23:1999;100-112.
76. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 16:1998;5-15.
77. Taylor R.N., de Groot C.J., Cho Y.K., Lim K.H. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol. 16:1998;17-31.
78. Spargo B.H., Lichtig C., Luger A.M., Katz A.I., Lindheimer M.D. The renal lesion in preeclampsia. Perspect Nephrol Hypertens. 5:1976;129-137.
79. Shanklin D.R., Sibai B.M. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol. 161:1989;735-741.
80. McCarthy A.L., Woolfson R.G., Raju S.K., Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol. 168:1993;1323-1330.
81. Knock G.A., Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 175:1996;1668-1674.
82. Kublickiene K.R., Grunewald C., Lindblom B., Nisell H. Myogenic and endothelial properties of myometrial resistance arteries from women with preeclampsia. Hypert Pregn. 17:1998;271-281.
83. Pascoal I.F., Lindheimer M.D., Nalbantian-Brandt C., Umans J.G. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest. 101:1998;464-470.
84. Goodman R.P., Killam A.P., Brash A.R., Branch R.A. Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol. 142:1982;817-822.
85. Fitzgerald D.J., Entman S.S., Mulloy K., Fitzgerald G.A. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy induced hypertension. Circulation. 75:1987;956-963.
86. Friedman S.A. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol. 71:1988;122-137.
87. Remuzzi G., Marchesi D., Zoja C., et al. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins. 20:1980;105-110.
88. Fitzgerald D.J., Rocki W., Murray R., Mayo G., Fitzgerald G.A. Thromboxane A2 synthesis in pregnancy induced hypertension. Lancet. 335:1990;751-754.
89. Ding Z., Rowe J., Sinosich M.J., et al. Serum from women with preeclampsia partially corrects the abnormal in vitro prostacyclin secretion of preeclamptic villous cytotrophoblasts but not that of prostaglandin E2 or endothelin-1. Am J Obstet Gynecol. 177:1997;1491-1495.
90. Walsh S.W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 152:1985;335-340.
91. ECPPA, ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group. Br J Obstet Gynaecol 1996;103:39-47.
92. Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 171:1994;944-948.
93. Davidge S.T., Stranko C.P., Roberts J.M. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol. 174:1996;1008-1013.
94. Curtis N.E., Gude N.M., King R.G., et al. Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypert Pregn. 173:1995;714-718.
95. Lyall F., Young A., Greer I.A. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol. 173:1995;714-718.
96. Nobunaga M., Tokugawa Y., Hashimoto K., et al. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest. 41:1996;189-193.
97. Smarason A.K., Allman K.G., Young D., Redman C.W. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br J Obstet Gynaecol. 104:1997;538-543.
98. Norris L.A., Higgins J.R., Darling M.R., Walshe J.J., Bonnar J. Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol. 93:1999;958-963.
99. Noris M., Morigi M., Donadelli R., et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 76:1995;536-543.
100. Kublickiene K.R., Cockell A.P., Nisell H., Poston L. Role of nitric oxide in the regulation of vascular tone in pressurized and perfused resistance myometrial arteries from term pregnant women. Am J Obstet Gynecol. 177:1997;1263-1269.
101. Cockell A.P., Poston L. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension. 30:1997;247-251.
102. Kublickiene KR, Lindblom B, Kruger K, Nisell H. Preeclampsia: evidence for impaired shear stress-mediated NO release in uterine circulation. Am J Obstet Gynecol 2000; In press:
103. Grunewald C., Kublickas M., Carlstrom K., Lunell N.O., Nisell H. Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol. 86:1995;600-604.
104. Giles W., OÇallaghan S., Boura A., Walters W. Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate. Lancet. 340:1992;856.
105. Garland C.J., Plane F., Kemp B.K., Cocks T.M. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 16:1995;23-30.
106. Campbell W.B., Harder D.R. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circulation Research. 84:1999;484-488.
107. Randall M.D., Alexander S.P., Bennett T., et al. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun. 229:1996;114-120.
108. Ashworth J.R., Baker P.N., Warren A.Y., Johnson I.R. Mechanisms of endothelium dependent relaxation in myometrial resistance vessels and their alterations in preeclampsia. Hypert Pregn. 18:1999;57-71.
109. Taylor R.N., Varma M., Teng N.N., Roberts J.M. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 71:1990;1675-1677.
110. Nisell H., Wolff K., Hemsen A., et al. Endothelin, a vasoconstrictor important to the uteroplacental circulation in pre-eclampsia. J Hypertens Suppl. 9:1991;S168-S169.
111. Tsunoda K., Abe K., Yoshinaga K., et al. Maternal and umbilical venous levels of endothelin in women with pre-eclampsia. J Hum Hypertens. 6:1992;61-64.
112. Florijn K.W., Derkx F.H., Visser W., et al. Elevated plasma levels of endothelin in pre-eclampsia. J Hypertens Suppl. 9:1991;S166-S167.
113. Kraayenbrink A.A., Dekker G.A., van Kamp G.J., VanGeyn H.P. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol. 169:1993;160-165.
114. Branch D.W., Dudley D.J., Mitchell M.D. Preliminary evidence for homoeostatic mechanism regulating endothelin production in pre-eclampsia. Lancet. 337:1991;943-945.
115. Belfort M.A., Saade G.R., Suresh M., Kramer W., Vedernikov Y.P. Effects of selected vasoconstrictor agonists on isolated omental artery from premenopausal non pregnant women and from normal and preeclamptic pregnant women. Am J Obstet Gynecol. 174:1996;687-693.
116. Wolff K., Kublickiene K.R., Kublickas M., et al. Effects of endothelin-1 and the ETA receptor antagonist BQ-123 on resistance arteries from normal pregnant and preeclamptic women. Acta Obstet Gynecol Scand. 75:1996;432-438.
117. Fievet P., Fournier A., de B.A., et al. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism. Am J Hypertens. 1:1988;16-21.
118. Kublickiene K.R., Grunewald C., Kublickas M., et al. Effects of atrial natriuretic peptide and cyclic guanosine monophosphate on isolated human myometrial arteries preconstricted by endothelin-1. Gynecol Obstet Invest. 40:1995;190-194.
119. McQueen J., Jardine A., Kingdom J., et al. Interaction of angiotensin II and atrial natriuretic peptide in the human fetoplacental unit. Am J Hypertens. 3:1990;641-644.
120. Grunewald C., Nisell H., Jansson T., et al. Possible improvement in uteroplacental blood flow during atrial natriuretic peptide infusion in preeclampsia. Obstet Gynecol. 84:1994;235-239.
121. Hayman R.G., Brockelsby J.C., Kenny L., Baker P.N. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig. 6:1999;3-10.
122. Baker P.N., Krasnow J., Roberts J.M., Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 86:1995;815-821.
123. Kupferminc M.J., Daniel Y., Englender T., et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 38:1997;302-306.
124. Sharkey A.M., Cooper J.C., Balmforth J.R., et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest. 26:1996;1182-1185.
125. Brockelsby J., Wheeler T., Anthony F.W., Wellings R., Baker P.N. Increased circulating levels of vascular endothelial growth factor in preeclampsia. Hypert Pregn. 17:1998;283-290.
126. Reuvekamp A., Velsing-Aarts F.V., Poulina I.E., Capello J.J., Duits A.J. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 106:1999;1019-1022.
127. Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 104:1997;223-228.
128. Anthony F.W., Evans P.W., Wheeler T., Wood P.J. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem. 34:1997;276-280.
129. Jackson M.R., Carney E.W., Lye S.J., Ritchie J.W. Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta. 15:1994;341-353.
130. Taylor C.M., Stevens H., Anthony F.W., Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG. JAr. Placenta. 18:1997;451-458.
131. Cooper J.C., Sharkey A.M., Charnock-Jones D.S., Palmer C.R., Smith S.K. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 103:1996;1191-1196.
132. Maloney J.P., Silliman C.C., Ambruso D.R., et al. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol. 275:1998;H1054-H1061.
133. Tsurumi Y., Murohara T., Krasinski K., et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 3:1997;879-886.
134. Broughton-Pipkin F. The renin-angiotensin system in normal and hypertensive pregnancies. Rubin P.C. Handbook of hypertension. Hypertension in pregnancy. 1988;118-151 Elsevier Science, Amsterdam.
135. Gant N.F., Daley G.L., Chand S., Whalley P.J., MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 52:1973;2682-2689.
136. Baker P.N., Kilby M.D., Pipkin F.B. The effect of angiotensin II on platelet intracellular free calcium concentration in human pregnancy. J Hypertens. 10:1992;55-60.
137. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 103:1999;945-952.
138. Hanssens M., Keirse M.J., Vankelecom F., Van Assche F.A. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 78:1991;128-135.
139. Nisell H., Hjemdahl P., Linde B. Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clin Physiol. 5:1985;479-493.
140. Allen J., Forman A., Maigaard S., Jespersen L.T., Andersson K.E. Effect of endogenous vasoconstrictors on maternal intramyometrial and fetal stem villous arteries in pre-eclampsia. J Hypertens. 7:1989;529-536.
141. Schobel H.P., Fischer T., Heuszer K., Geiger H., Schmieder R.E. Preeclampsia - a state of sympathetic overactivity. N Engl J Med. 335:1996;1480-1485.
142. Jensen P.E., Mulvany M.J., Aalkjaer C. Endogenous and exogenous agonist-induced changes in the coupling between [Ca2+]i and force in rat resistance arteries. Pflugers Arch. 420:1992;536-543.
143. Aalkjaer C., Danielsen H., Johannesen P., et al. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. Clin Sci. 69:1985;477-482.
144. Bakker ENTP, Van der Meulen ET, Spaan JAE, VanBavel E. Organoid culture of cannulated rat resistance arteries. Effect of serum factors on vasoactivity and remodeling. Am J Physiol 1999; In press.
145. Malee M.P., Malee K.M., Azuma S.D., Taylor R.N., Roberts J.M. Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. J Clin Endocrinol Metab. 74:1992;1095-1100.